Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GBA-associated PD: chances and obstacles for targeted treatment strategies
Günter U. Höglinger, Claudia Schulte, Wolfgang H. Jost, et al.
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1219-1233
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
Günter U. Höglinger, Charles H. Adler, Daniela Berg, et al.
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 191-204
Closed Access | Times Cited: 239
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease
Kathrin Brockmann, Stefanie Lerche, Simone Baiardi, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 29
Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s disease
Cleusa Adriane Menegassi Bianchi Krüger, Shen‐Yang Lim, Alissa Buhrmann, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
Laura Muñoz‐Delgado, Daniel Macías‐García, María Teresa Periñán, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 33
Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic
Shen‐Yang Lim, Ai Huey Tan, Azlina Ahmad, et al.
The Lancet Neurology (2024)
Closed Access | Times Cited: 10
A Phase 1B Trial in GBA1‐Associated Parkinson's Disease of BIA‐28‐6156, a Glucocerebrosidase Activator
Jonas M. den Heijer, Annelieke C. Kruithof, Matthijs Moerland, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1197-1208
Open Access | Times Cited: 22
The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
Eddie Pradas, Marta Martínez‐Vicente
Cells (2023) Vol. 12, Iss. 1, pp. 191-191
Open Access | Times Cited: 20
Are patients with GBA–Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort
Micol Avenali, Roberta Zangaglia, Giada Cuconato, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023), pp. jnnp-332387
Open Access | Times Cited: 20
Towards a Biological Definition of Parkinson’s Disease
Günter U. Höglinger, Charles H. Adler, Daniela Berg, et al.
(2023)
Open Access | Times Cited: 18
Genetics of Parkinson’s Disease: state-of-the-art and role in clinical settings
Jarosław Dulski, Owen A. Ross, Zbigniew K. Wszołek
Neurologia i Neurochirurgia Polska (2024) Vol. 58, Iss. 1, pp. 38-46
Open Access | Times Cited: 8
The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson’s Disease: a New Genetic State of the Art
Júlio César Claudino dos Santos, Gabriela Braga Cabrera Mano, André Rodrigues da Cunha Barreto Vianna, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6754-6770
Closed Access | Times Cited: 7
Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
Yıldız Değirmenci, Efthalia Angelopoulou, Vasiliki Georgakopoulou, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1756-1756
Open Access | Times Cited: 16
GBA1 Variants and Parkinson’s Disease: Paving the Way for Targeted Therapy
Young Eun Huh, Tatiana Usnich, Clemens R. Scherzer, et al.
Journal of Movement Disorders (2023) Vol. 16, Iss. 3, pp. 261-278
Open Access | Times Cited: 15
Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study
Sinthuja Pachchek, Zied Landoulsi, Lukas Pavelka, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Proxy-analysis of the genetics of cognitive decline in Parkinson’s disease through polygenic scores
Johann Faouzi, Manuela Tan, Fanny Casse, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Acetal functionalized iminosugars for targeting β-glucocerebrosidase modulation
Maria Giulia Davighi, Francesca Clemente, Camilla Matassini, et al.
European Journal of Medicinal Chemistry (2025), pp. 117529-117529
Closed Access
Penetrance of Parkinson's disease in GBA1 carriers depends on the variant severity and polygenic background
Emadeldin Hassanin, Zied Landoulsi, Sinthuja Pachchek, et al.
Research Square (Research Square) (2025)
Closed Access
Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
Jan Philipp Dobert, Simon Bub, Rebecca Mächtel, et al.
Advanced Science (2024) Vol. 11, Iss. 25
Open Access | Times Cited: 3
Structural and dynamics insights into the GBA variants associated with Parkinson’s disease
Arif Mahmood, Abdus Samad, Shazia Bano, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6256-6268
Closed Access | Times Cited: 7
What can pediatricians learn from adult inherited metabolic diseases?
Fanny Mochel
Journal of Inherited Metabolic Disease (2024) Vol. 47, Iss. 5, pp. 876-884
Open Access | Times Cited: 2
Parkinson's Disease Gene Screening in Familial Cases from Central and South America
Oswaldo Lorenzo‐Betancor, Seysha Mehta, Janvi Ramchandra, et al.
Movement Disorders (2024) Vol. 39, Iss. 10, pp. 1843-1855
Closed Access | Times Cited: 2
Combining Biomarkers with Genetics In Prodromal/Earliest Phase Parkinson’s Disease
Philip Seibler, Linn Streubel-Gallasch, Christine Klein
Journal of Parkinson s Disease (2024), pp. 1-7
Open Access | Times Cited: 2
Gene Signals and SNPs Associated with Parkinson’s Disease: A Nutrigenomics and Computational Prospective Insights
Swetha Subramaniyan, Beena Briget Kuriakose, Sakeena Mushfiq, et al.
Neuroscience (2023) Vol. 533, pp. 77-95
Closed Access | Times Cited: 4
Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM study
Daniel Weiß, Zied Landoulsi, Patrick May, et al.
Parkinsonism & Related Disorders (2022) Vol. 103, pp. 169-174
Closed Access | Times Cited: 7
Longitudinal faster anxiety progression of GBA variant carriers in the early Parkinson’s disease cohort
Shushan Sang, Yunpeng Ba, Nannan Yang
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top